Related Experiment Video
Updated: Sep 25, 2026
Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Specificity of growth inhibition of melanoma by 4-hydroxyanisole
1Winthrop-University Hospital, Mineola, New York 11501.
Abstract:
An experimental study using human melanoma (NEL-MI), rat hepatoma (Fu5-5), and human kidney (293-31) cell lines was undertaken in order to evaluate the antitumor activity of 4-hydroxyanisole (4-OHA) in vitro. Prior reports have indicated highly specific antitumor activity of 4-OHA against melanoma cells in vitro. This specific antitumor activity has been proposed to be due to the oxidation of 4-OHA by tyrosinase to cytotoxic oxidation products. Dose-dependent cytotoxicity was observed when cells were cultured for 72 h in the presence of 4-OHA. At 100 microM, 4-OHA produced growth inhibition of 62%, 32%, and 55% in melanoma, hepatoma, and kidney cell lines, respectively. No effect was seen at 10 microM 4-OHA. 1,000 microM 4-OHA produced 100% kill. Tyrosinase activity was detected only in melanoma cells. The effect of 100 microM 4-OHA on the incorporation of 3H DNA precursors in melanoma, hepatoma, and kidney cells was also studied. Thymidine incorporation was inhibited in all three cell lines at the lowest cell density tested, with the greatest inhibition seen on melanoma cells. As cell density increased, the effect of 4-OHA on thymidine incorporation decreased. With respect to RNA synthesis, 4-OHA significantly reduced the incorporation of uridine in all three cell lines, with the greatest effect in melanoma cells. Cell density also affected the inhibition of uridine incorporation, but to a lesser extent than that observed on thymidine incorporation. The effect of 4-OHA on leucine incorporation was modest and uninfluenced by cell density. Thus, cytotoxicity of 4-OHA may involve two different mechanisms.(ABSTRACT TRUNCATED AT 250 WORDS)
Insights
4-hydroxyanisole (4-OHA) exhibits dose-dependent antitumor activity against melanoma, hepatoma, and kidney cells in vitro. Its cytotoxicity appears to involve tyrosinase-dependent mechanisms and impacts DNA and RNA synthesis, particularly in melanoma cells.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- 4-hydroxyanisole (4-OHA) has shown prior specific antitumor activity against melanoma cells in vitro.
- This activity is hypothesized to result from tyrosinase-mediated oxidation of 4-OHA into cytotoxic products.
Purpose of the Study:
- To evaluate the in vitro antitumor activity of 4-hydroxyanisole (4-OHA) against human melanoma, rat hepatoma, and human kidney cell lines.
- To investigate the mechanisms underlying 4-OHA's cytotoxicity, including its effect on DNA, RNA, and protein synthesis.
Main Methods:
- Experimental study utilizing human melanoma (NEL-MI), rat hepatoma (Fu5-5), and human kidney (293-31) cell lines.
- Dose-response cytotoxicity assays with varying concentrations of 4-OHA.
- Measurement of tyrosinase activity in cell lines.
- Assessment of 3H-thymidine, uridine, and leucine incorporation to evaluate DNA, RNA, and protein synthesis, respectively.
Main Results:
- 4-OHA demonstrated dose-dependent cytotoxicity across all tested cell lines, with significant growth inhibition observed at 100 microM.
- Tyrosinase activity was exclusively detected in melanoma cells.
- 4-OHA inhibited thymidine and uridine incorporation in all cell lines, with the most pronounced effects on melanoma cells, and this inhibition was cell density-dependent.
- Leucine incorporation was modestly affected by 4-OHA, independent of cell density.
Conclusions:
- 4-hydroxyanisole exhibits broad-spectrum in vitro antitumor activity, with a notable impact on melanoma cells.
- The cytotoxicity of 4-OHA likely involves multiple mechanisms, including tyrosinase-dependent pathways and interference with nucleic acid synthesis.
- Cell density influences the impact of 4-OHA on DNA and RNA synthesis, suggesting complex cellular interactions.
